Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer

May 28, 2024

https://www.globenewswire.com/news-release/2024/05/28/2888860/0/en/Nurix-Therapeutics-Appoints-Paula-G-O-Connor-M-D-as-Chief-Medical-Officer-and-Pasit-Phiasivongsa-Ph-D-as-Chief-Technical-Officer.html

SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq:NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced the appointments of Paula G. O’Connor, M.D., as chief medical officer and Pasit Phiasivongsa, Ph.D., as chief technical officer of Nurix.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.